Genome biologyGenomicsPeer-reviewed journal article
Single cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers
Farhia KabeeriD, Hoa TraniD, Mirela Andronescu, Gurdeep SinghiD, Hakwoo Lee, Sohrab SalehiiD, Beixi WangiD, Justina BieleiD, Jazmine BrimhalliD, David Gee, Viviana Cerda, Ciara H. O’FlanaganiD, Teresa Ruiz de Algara, Takako Kono, Sean BeattyiD, Elena ZaikovaiD, Daniel LaiiD, Eric LeeiD, Richard A. MooreiD, Andrew J. J. MungalliD, Marc J. WilliamsiD, Andrew J. L. RothiD, Kieran R. CampbelliD, Sohrab P. ShahiD, Samuel A. J. R. AparicioiD
Abstract
BackgroundThe encoding of cell intrinsic resistance states in breast cancer reflects the contributions of genomic and non-genomic variation. However, identifying the potential contributions of each requires accurate measurement and subtraction of the contribution of clonal fitness from co-measurement of transcriptional states. Somatic genomic variation in gene dosage, copy number variation, is the dominant mutational mechanism in breast cancer contributing to transcriptional variation and has recently been shown to contribute to platinum chemotherapy resistance states. Here we deploy time series measurements of triple negative breast cancer single cell transcriptomes in conjunction with co-measured single cell copy number associated clonal fitness to identify the contributions of genomic and non-genomic mechanisms to drug associated transcription states. ResultsWe generated serial scRNA-seq data (126,556 cells) from triple negative breast cancer (TNBC) patient-derived xenograft (PDX) experiments over 2.5 years in duration, and matched it against genomic copy number single cell data from the same biological samples. We show that the cell memory of transcriptional states of TNBC tumors serially exposed to platinum identifies distinct clonal responses within individual tumours. Copy-number clones with high drug fitness leading to clonal sweeps exhibit less transcriptional reversion, whereas clones with weak drug fitness exhibit highly dynamic transcription on drug withdrawal. Pathway analysis shows that copy number associated and copy number independent transcripts converge on epithelial-mesenchymal transition (EMT) and cytokine signaling states associated with resistance. We show from trajectory analysis that transcriptional reversion exhibits hysteresis, indicating that new intermediate transcriptional states are generated by platinum exposure. ConclusionsWe discovered that copy number clones with strong genotype associated fitness under platinum became fixed in their states, resulting in minimal transcriptional reversion on drug withdrawal. In contrast clones with weaker fitness undergo non-genomic transcriptional plasticity and these distinct responses co-exist within single tumours. Together the data suggest that copy number associated and copy number independent transcriptional states may contribute to platinum drug resistance within individual tumours. The dominance of genomic or non-genomic mechanisms within individual polyclonal tumours has implications for approaches to restoration of drug sensitivity and re-treatment strategies. Data availabilityUploaded Data URL: https://ega-archive.org/studies/EGAS00001007242 Github manuscript: https://github.com/molonc/drug_resistant_material/
- Citations
- 8
- FWCI
- 1.09
- Field percentile
- top 26%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chemotherapy reshapes cellular clonal landscape via persister programs in breast cancer xenografts
Sarah Kronheim, J C M Wang, … Long V. Nguyen·bioRxiv·Apr 6, 2026
- Deciphering the gene regulatory circuitry governing chemoresistance in Triple-Negative Breast Cancer
R. Lusby, A. Mariappan, … V. K. Tiwari·bioRxiv·May 5, 2023
- Development of Paclitaxel Resistance in Triple-Negative Breast Cancer Is Associated with Extensive DNA Methylation Changes That Are Partially Reversed by Decitabine
Lenka Trnkova, Monika Buríková, … Božena Smolková·Drug Resistance UpdatesPeer-reviewed·Jan 2, 2026
- Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies.
S. A. Wild, I. G. Cannell, … K. Sawicka·bioRxiv·Dec 9, 2021
- Lineage Tracing Reveals Clone-Specific Responses to Doxorubicin in Triple-Negative Breast Cancer
Daylin Morgan, Andrea L. Gardner, Amy Brock·bioRxiv·Mar 18, 2025
- Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy
S. P. Hong, T. E. Chan, … L. Magnani·bioRxiv·Dec 2, 2018